If you're considering switching from branded GLP-1 medications to compounded formulations, understanding pharmacokinetics helps ensure continuity of care
FTH1- and SAT1-induced astrocytic ferroptosis is involved in Alzheimers disease: evidence from single-cell transcriptomic analysis
Neurotherapeutics entry into CSF is reported for many CNS diseases, however it does not provide information if drug may readily cross the BBB, and reach to the neuronal target
Historically, the understanding of the effects of glucosinolates on skeletal muscle comes from trials of their application in animal production settings, with results indicating that although growth performance may be affected, muscle had an improved antioxidant status and fatty acid profile (Skugor et al., 2019)
- *ASCVD*: Subcutaneous semaglutide (up to 1 mg weekly dose) is recommended as the preferred GLP-1 receptor agonist for patients with established cardiovascular disease
Sublingual B12 sprays such as the Super Shot are also more natural since they do not include certain binding agents and additives used in many B12 capsules